Advanced search
Publication Cover
Journal of Asthma Volume 58, 2021 - Issue 10
Submit an article Journal homepage
923
Views
23
CrossRef citations to date
0
Altmetric
Treatment

Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis

Zhuo Fua Tianjin Medical University, Tianjin, PR China;b Respiratory Department, Tianjin Children’s Hospital, Tianjin, PR ChinaView further author information
, MD,
Yongsheng Xub Respiratory Department, Tianjin Children’s Hospital, Tianjin, PR ChinaView further author information
, MD &
Chunquan Caic Department of Neurosurgery, Tianjin Institute of Pediatrics, Tianjin Children’s Hospital, Tianjin, PR ChinaCorrespondence[email protected]
View further author information
, MD, PhD
Pages 1350-1358 | Received 13 Apr 2020, Accepted 26 Jun 2020, Published online: 16 Jul 2020

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carlos E. Rodriguez-Martinez & Monica P. Sossa-Briceño. (2022) Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?. Journal of Asthma 59:7, pages 1360-1371.
Read now

Articles from other publishers (22)

Cristiana Indolfi, Angela Klain, Chiara Lucia Bencivenga, Elisabetta D'Addio, Giulio Dinardo, Alberto Decimo & Michele Miraglia del Giudice. (2024) Biological Drugs for the Treatment of Uncontrolled Severe Asthma in Children. Current Pediatric Reviews 20:3, pages 265-270.
Crossref
Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, Paolo Barraco, Stefano Passanisi, Antonella Gambadauro, Giuseppe Crisafulli, Mariella Valenzise & Sara Manti. (2024) Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study. Children 11:2, pages 170.
Crossref
Rehana A. Salam, Maryam Hameed Khan, Syed Saqlain Ali Meerza, Jai K. Das, Laura Lewis-Watts & Zulfiqar A. Bhutta. (2024) An evidence gap map of interventions for noncommunicable diseases and risk factors among children and adolescents. Nature Medicine 30:1, pages 290-301.
Crossref
Ianthe R.M. Schepel, Tina M. Banzon & Wanda Phipatanakul. (2024) Future of biologics in pediatric asthma. Annals of Allergy, Asthma & Immunology 132:1, pages 13-20.
Crossref
Nurlan N. Brimkulov & Denis V. Vinnikov. (2023) Bronchial asthma and work in high-altitude mines. Russian Journal of Occupational Health and Industrial Ecology 63:12, pages 826-829.
Crossref
Yoni E. van Dijk, Niels W. Rutjes, Korneliusz Golebski, Havva Şahin, Simone Hashimoto, Anke-Hilse Maitland-van der Zee & Susanne J. H. Vijverberg. (2023) Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab. Pediatric Drugs 25:6, pages 677-693.
Crossref
Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina & Manuel Sanchez-Solis. (2023) Severe Asthma and Biological Therapies: Now and the Future. Journal of Clinical Medicine 12:18, pages 5846.
Crossref
Sergio Romero-Tapia, Crystell Guzmán Priego, Blanca Del-Río-Navarro & Manuel Sánchez-Solis. (2023) Advances in the Relationship between Respiratory Viruses and Asthma. Journal of Clinical Medicine 12:17, pages 5501.
Crossref
K. O. Shnaider, M. L. Maksimov & B. K. Romanov. (2023) Safety of omalizumab in children. Glavvrač (Chief Medical Officer):7, pages 34-47.
Crossref
Francesca Galletta, Lucia Caminiti, Cecilia Lugarà, Simone Foti Randazzese, Paolo Barraco, Federica D’Amico, Pierangela Irrera, Giuseppe Crisafulli & Sara Manti. (2023) Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life. Journal of Personalized Medicine 13:7, pages 1068.
Crossref
Aimee Sutherland, Karen Keniston, Vivian Wang & Joseph Yusin. (2023) Updates in the Role of Biologics in Asthma. Current Treatment Options in Allergy 10:3, pages 232-254.
Crossref
Elizabeth Scotney, Louise Fleming, Sejal Saglani, Samatha Sonnappa & Andrew Bush. (2023) Advances in the pathogenesis and personalised treatment of paediatric asthma. BMJ Medicine 2:1, pages e000367.
Crossref
K. O. Shnaider, M. L. Maksimov, B. K. Romanov & V. A. Baranova. (2023) Biological drugs in the treatment of atopic diseases in pediatric patients. Glavvrač (Chief Medical Officer):3, pages 15-35.
Crossref
Grazia Fenu, Andrea La Tessa, Claudia Calogero & Enrico Lombardi. (2023) Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile. Frontiers in Pediatrics 10.
Crossref
Sara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo & Salvatore Leonardi. (2022) Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review. European Respiratory Review 31:165, pages 220011.
Crossref
Sukhwinder Singh Sohal. (2022) Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19: Insights from the Special Issue. Journal of Clinical Medicine 11:15, pages 4525.
Crossref
. (2022) III. PLENARY LECTURES. Pediatric Pulmonology 57:S2.
Crossref
Guy G. Brusselle & Gerard H. Koppelman. (2022) Biologic Therapies for Severe Asthma. New England Journal of Medicine 386:2, pages 157-171.
Crossref
Svetlana V. Zaytseva, Anna U. Tomilova, Olga V. Zaytseva, Olga B. Voronina, Olga A. Murtazaeva, Valeriy A. Mukhortykh & Irina N. Tsymbal. (2021) Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma. Pediatric pharmacology 18:6, pages 460-468.
Crossref
Svetlana V. Zaytseva, Anna U. Tomilova, Olga V. Zaytseva, Olga B. Voronina, Olga A. Murtazaeva, Valeriy A. Mukhortykh & Irina N. Tsymbal. (2021) Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma. Pediatric pharmacology, pages 364-372.
Crossref
Carlos E. Rodriguez‐Martinez, Monica P. Sossa‐Briceño & Jose A. Castro‐Rodriguez. (2021) Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country. Pediatric Pulmonology 56:9, pages 2987-2996.
Crossref
Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Morgan Harris, Amy B.W. LaMothe, Pourya Pourhosseini & Ann M. Lynch. 2021. 197 206 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.